Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types;Farkli atriyal fibrilasyon türlerinde plazma renin aktivitesi ve pro-B-tipi natriüretik peptit düzeyleri

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 4, 2010, Pages 317-322

  Doǧan, Abdullah ^a   Gedikli, Ömer ^b   Özaydin, Mehmet ^a   Acar, Gürkan ^c  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; B type natriuretic peptide; Logistic regression analysis; Plasma renin activity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POPULATION RESEARCH; PREDICTOR VARIABLE; SINUS RHYTHM;

ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT SELECTION; PEPTIDE FRAGMENTS; REFERENCE VALUES; RENIN;

EID: 77955784921     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.089     Document Type: Article

References (25)

1. Birnie DH, Gallop M, Healey JS. Clinical trials, the renin angiotensin system and atrial fibrillation. Curr Opin Cardiol 2006; 21: 368-75.
2. Tsai CT, Lai LP, Hwang JJ, Chen WP, Chiang FT, Hsu KL, et al. Reninangiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. J Hypertens 2008; 26: 570-82.
3. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35: 1669-77.
4. Li D, Pang L, Leung TK, Cardin S, Wang Z, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacinginduced congestive heart failure. Circulation 2001; 104: 2608-14.
5. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-7.
6. Goette A, Arndt M, Rocken C, Spiess A, Staack T, Geller C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000; 101: 2678-81.
7. Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 2003; 42: 1785-92.
8. Zupan I, Krhin B, Breskvar U, Zupan IP, Rakovec P. Effects of systolic atrial function on plasma rennin activity and natriuretic peptide secretion after high atrial and ventricular pacing in dogs. Pacing Clin Electrophysiol 2005; 28: S270-4.
9. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000; 6: 92-6.
10. Asselbergs FW, Van Den Berg MP, Bakker SJ, Signorovitch JE, Hillege HL, Van Gilst WH, et al. N terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort. Neth Heart J 2008; 16: 73-8.
11. Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003; 92: 1124-7.
12. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005; 45: 82-6.
13. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004; 93: 1555-8.
14. Morello A, Lloyd-Jones DM, Chae CU, Van Kimmenade RR, Chen AC, Baggish AL, et al. Association of atrial fibrillation and aminoterminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007; 153: 90-7.
15. Buob A, Jung J, Siaplaouras S, Neuberger HR, Mewis C. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2006; 29: 559-63.
16. Badran HM, Eid MA, Michael A. Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study. Echocardiography 2007; 24: 911-22.
17. Kim BJ, Hwang SJ, Sung KC, Kim BS, Kang JH, Lee MH, et al. Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function. Int J Cardiol 2007; 118: 145-50.
18. Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. Int J Cardiol 2009; 131: 234-9.
19. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 1997; 96: 3737-44.
20. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van Den Berg MP, De Kam PJ, Crijns HJ. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 1998; 81: 1207-10.
21. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation 2004; 109: 2839-43.
22. Rossi A, Enriquez-Sarano M, Burnett JC, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000; 35: 1256-62.
23. Dixen U, Ravn L, Soeby-Rasmussen C, Paulsen AW, Parner J, Frandsen E, et al. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation. Cardiology 2007; 108: 35-9.
24. Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 2006; 27: 2353-61.
25. Tuinenburg AE, Brundel BJ, Van Gelder IC, Henning RH, Van Den Berg MP, Driessen C, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10: 827-35.